Gene and immunohistochemical expression of HIF-1α, GLUT-1, FASN, and adipophilin in carcinoma ex pleomorphic adenoma development. Oral Diseases.
Odontogenic Carcinoma With Dentinoid in Long-Term Follow-up With 2 Recurrences. International Journal of Surgical Pathology.
Epigenetic alterations in salivary gland tumors. Oral Diseases.
GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation. Scientific Reports.
CTNNB1 and APC mutations in odontogenic carcinoma with dentinoid. Oral Surgery Oral Medicine Oral Pathology Oral Radiology.
Somatic copy number alterations in pleomorphic adenoma and recurrent pleomorphic adenoma. Oral Surgery Oral Medicine Oral Pathology Oral Radiology.
Immunohistochemical expression of mammaglobin in salivary duct carcinomas (SDC) de novo and SDC ex pleomorphic adenoma. Human Pathology.
Fatty acid synthase and Ki‐67 immunoexpression can be useful for the identification of malignant component in carcinoma ex‐pleomorphic adenoma. Journal of Oral Pathology & Medicine.
Evaluation of the expression of Bmi-1 stem cell marker in sinonasal melanomas and its correlation with the expression of cell cycle proteins. Surgical and Experimental Pathology.
Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression. Modern Pathology.
Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients. Oncotarget.
Genomic profile of a squamous cell carcinoma ex pleomorphic adenoma compared to a head and neck squamous cell carcinoma. Brazilian Journal of Otorhinolaryngology.
D2-40/podoplanin expression in chronic villitis of the placenta. Jornal Brasileiro de Patologia e Medicina Laboratorial.
Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome. Virchows Archiv.
XPDc.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation. Oncotarget.
Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation. Brazilian Journal of Otorhinolaryngology.
Lysozyme expression can be useful to distinguish mammary analog secretory carcinoma from acinic cell carcinoma of salivary glands. Head and Neck Pathology.
Evaluation of a subset of tumor suppressor gene for copy number and epigenitic changes in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma carcinogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol.
Association between polymorphisms in genes related to DNA base-excision repair with risk and prognosis of oropharyngeal squamous cell carcinoma. J Cancer Res Clin Oncol.
Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma. Hum Pathol.
PLAG1 expression is maintained in recurrent pleomorphic adenoma. Virchows Arch.
Carcinoma ex-pleomorphic adenoma of upper lip showing copy number loss of tumor suppressor genes. Oral Surg Oral Med Oral Pathol Oral Radiol.
Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma. Braz Dent J.
Mammary analogue secretory carcinoma of salivary glands is a lipid-rich tumour, and adipophilin can be valuable in its identification. Histopathology.
Age and adenoma size are independent risk factors for the development of carcinoma ex pleomorphic adenoma. Oral Oncology.